Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ads free!Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ads free today!Spring sale! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

AbbVie
Biotech
Gilead Sciences
Topics

Advertisement

AbbVie

Share

Top Latest Popular

In the last 15 minutes

Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson? The Motley Fool 21:11

Earlier Today

AbbVie to Present at the Bank of America Securities Healthcare Conference PR Newswire (Press Release) 13:03

Yesterday

S&P 500 Analyst Moves: ABBV Nasdaq 19:06 Tue, 05 May

Advertisement

Advertisement

AbbVie Achieves #77 Analyst Rank, Surpassing Ball Nasdaq 19:06 Tue, 05 May

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? Zacks 15:08 Tue, 05 May

Zifo's SiEE Boston Summit Charts New Roadmap for 'Practical AI' in Life Sciences, Bridging the Gap Between Business Vision and Lab Reality PR Newswire (Press Release) 14:09 Tue, 05 May

Clio Health Champions: Madhuri Shah, Head of Marketing – Vyalev, AbbVie Muse by Clio 14:02 Tue, 05 May

AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week® PR Newswire (Press Release) 13:07 Tue, 05 May

Monday

AbbVie's Latest Results Reveal a Trend Investors Shouldn't Overlook The Motley Fool 21:52 Mon, 04 May

AbbVie Regulatory Submission and Deal News JD Supra 18:03 Mon, 04 May

US FDA declines to approve AbbVie's wrinkle treatment due to manufacturing concerns (April 23) The Tribune, California 17:49 Mon, 04 May

Thursday

Should AbbVie’s (ABBV) Immunology Strength and Raised Outlook Offset Earnings Dip for Investors? Simply Wall St 02:56 Thu, 30 Apr

AbbVie's patent on immunology therapy rejected The Times of India 01:37 Thu, 30 Apr

In the last month

AbbVie Thrives on New Drug Demand ShareCafe 22:51 Wed, 29 Apr

AbbVie Is Looking To Business Development To Backstop I&I Strength Scrip Pharma Intelligence 22:14 Wed, 29 Apr

AbbVie Earnings: Immunology Portfolio and Pipeline Look Solid MorningStar.com 20:40 Wed, 29 Apr

AbbVie outlines Skyrizi defense against new J&J plaque psoriasis rival Icotyde FiercePharma 19:58 Wed, 29 Apr

AbbVie Thanks 'Excellent Start To 2026' To Immunology And Neuroscience Strength Benzinga 19:55 Wed, 29 Apr

Advertisement

AbbVie Seeks Early Win Over HHS In Botox Drug Price Suit Law360 19:11 Wed, 29 Apr

ABBV Beats on Q1 Earnings & Sales, Raises '26 EPS View Zacks 17:35 Wed, 29 Apr

AbbVie (ABBV) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates Zacks 17:04 Wed, 29 Apr

AbbVie (ABBV) Tops Q1 Earnings and Revenue Estimates Zacks 15:22 Wed, 29 Apr

AbbVie’s (NYSE:ABBV) Q1 CY2026 Sales Top Estimates Barchart 13:23 Wed, 29 Apr

AbbVie Reports First-Quarter 2026 Financial Results PR Newswire (Press Release) 12:47 Wed, 29 Apr

AbbVie Seeks FDA Approval To Expand Rinvoq Use For Alopecia Areata RTT News 08:37 Wed, 29 Apr

Curogen, Epibiotech win 1st AbbVie-KHIDI biotech award Korea Biomedical Review 03:13 Wed, 29 Apr

AbbVie, Roche cut donations despite strong revenue growth in Korea in 2025 Korea Biomedical Review 02:20 Wed, 29 Apr

AbbVie Seeks Pan-KRAS Position With Kestrel Financing And Option Deal Scrip Pharma Intelligence 22:29 Tue, 28 Apr

Should You Buy AbbVie Stock Hand Over Fist Before April 29? The Motley Fool 17:28 Tue, 28 Apr

AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata AbbVie (Press Release) 13:02 Tue, 28 Apr

AbbVie's Planned $1B-Plus Research Triangle Campus Development Buoys Improved Life Sciences Outlook Bisnow 23:03 Mon, 27 Apr

AbbVie Submits Regulatory Application to FDA for SKYRIZI® (risankizumab-rzaa) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease PR Newswire (Press Release) 13:05 Mon, 27 Apr

AbbVie Announces $1.4 Billion North Carolina Campus To Expand U.S. Pharmaceutical Manufacturing Capacity Pharmaceutical Online 13:04 Mon, 27 Apr

AbbVie's TrenibotE Receives FDA CRL Due to Manufacturing Issues Zacks 18:29 Fri, 24 Apr

FDA snubs AbbVie's prospective Botox heir amid series of manufacturing-related CRLs FiercePharma 16:49 Fri, 24 Apr

Insights Into AbbVie (ABBV) Q1: Wall Street Projections for Key Metrics Zacks 15:25 Fri, 24 Apr

AbbVie Faces FDA Rejection On Manufacturing Issues For Wrinkle Drug Benzinga 13:52 Fri, 24 Apr

FDA declines to approve AbbVie's Botox follow-up pharmaphorum 11:25 Fri, 24 Apr

AbbVie expands US footprint with new $1.4 billion manufacturing campus European Pharmaceutical Review 11:23 Fri, 24 Apr

15 Press Releases You Need to See This Week PR Newswire (Press Release) 11:06 Fri, 24 Apr

Advertisement

Advertisement

AbbVie News

NewsNow aims to be the world's most accurate and comprehensive aggregator of AbbVie news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna